Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

L

LGND

Ligand Pharmaceuticals Inc

294.73

Jul 27 • 2:07 PM ET -5.80 (-1.93%)

Healthcare Biotechnology USA Mid NASD

Peers: BMRN IONS RYTM VKTX ALNY INCY AXSM MDGL KROS NBIX

| Held by: IJR VTI IWM VB VBR VXF XSMO SPSM IJT IWO

Scroll to Statements

Index	RUT
Market Cap	5.91B
Enterprise Value	5.58B
Income	153.56M
Sales	274.48M
Book/sh	49.79
Cash/sh	38.89
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	Jul 02, 2010
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	47
IPO	Nov 18, 1992

P/E	39.96
Forward P/E	25.41
PEG	1.31
P/S	21.52
P/B	5.92
P/C	7.58
P/FCF	47.98
EV/EBITDA	41.10
EV/Sales	20.33
Quick Ratio	20.95
Current Ratio	21.28
Debt/Eq	0.45
LT Debt/Eq	0.45
Option/Short	Yes / Yes

EPS (ttm)	7.38
EPS next Y	11.60
EPS next Q	1.84
EPS this Y	12.37%
EPS next Y	26.97%
EPS next 5Y	19.36%
EPS past 3/5Y	- -
Sales past 3/5Y	10.96% 7.54%
EPS Y/Y TTM	210.12%
Sales Y/Y TTM	51.24%
EPS Q/Q	69.66%
Sales Q/Q	14.09%
Earnings	Aug 06 BMO
EPS/Sales Surpr.	-10.23% -11.88%

Insider Own	2.47%
Insider Trans	-12.20%
Inst Own	106.10%
Inst Trans	1.69%
ROA	12.60%
ROE	17.13%
ROIC	10.60%
Gross Margin	83.42%
Oper. Margin	36.88%
Profit Margin	55.95%
SMA20	-4.35%
SMA50	9.17%
SMA200	35.19%
Trades

Shs Outstand	20.03M
Shs Float	19.55M
Short Float	9.81%
Short Ratio	5.52
Short Interest	1.92M
52W High	326.63 -9.77%
52W Low	129.55 127.51%
Volatility	3.33% 3.83%
ATR (14)	11.22
RSI (14)	50.66
Beta	1.16
Rel Volume	0.71
Avg Volume	347.63K
Volume	178,271

Perf Week	0.25%
Perf Month	-0.40%
Perf Quarter	27.44%
Perf Half Y	46.52%
Perf YTD	55.89%
Perf Year	116.99%
Perf 3Y	337.03%
Perf 5Y	279.30%
Perf 10Y	235.68%
Recom	1.00
Target Price	323.30
Prev Close	300.53
Price	294.73
Change	-1.93%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)